XMIL
ELEN
Market cap788mUSD
Oct 21, Last price
17.88EUR
Name
El En SpA
Chart & performance
P/E
33.13
P/S
2.43
EPS
0.54
Vol. 1Y
—
Shs. 5Y
-0.03%
Rev. 5Y
7.68%
Div Yld LY
—
Div Yld TTM
—
Revenues
591m
+4.42%
Net income
43m
-15.89%
CFO
71m
-14.75%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
EL.En. S.p.A. is a global leader in the development, manufacturing, marketing, and distribution of advanced laser systems. The company supplies a wide array of medical laser equipment for applications in physiotherapy, orthopedics, traumatology, rheumatology, dermatology, sports and rehabilitative medicine, surgery, aesthetics, and art. Additionally, EL.En. offers industrial laser sources and integrated systems engineered for precise cutting, welding, marking, and engraving across numerous materials. Its product portfolio includes various laser source technologies, such as liquid, solid-state, semiconductor, and gas lasers. Complementing its product offerings, the company provides comprehensive after-sales services, including spare parts supply, expert consultation, and technical support. Established in 1981, EL.En. S.p.A. is headquartered in Calenzano, Italy.
Related entities
Subsidiaries (4)
CUTLITE PENTA S.P.A
DEKA M.E.L.A. - S.R.L.
LASIT - SISTEMI E TECNOLOGIE ELETTROTTICHE - S.P.A.
QUANTA SYSTEM S.P.A.
Headquarters & legal address
VIA BALDANZESE, 17
CALENZANO, FI 50041
IT
CALENZANO, FI 50041
IT
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||